Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Biomarker Research |
| Online Access: | https://doi.org/10.1186/s40364-025-00819-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849343070938595328 |
|---|---|
| author | Tzu-Chun Cheng Mien-Chie Hung Lu-Hai Wang Shih-Hsin Tu Chih-Hsiung Wu Yun Yen Chi-Long Chen Jacqueline Whang-Peng Wen-Jui Lee You-Cheng Liao Yu-Ching Lee Min-Hsiung Pan Hui-Kuan Lin Huey-En Tzeng Peixuan Guo Cheng-Ying Chu Li-Ching Chen Yuan-Soon Ho |
| author_facet | Tzu-Chun Cheng Mien-Chie Hung Lu-Hai Wang Shih-Hsin Tu Chih-Hsiung Wu Yun Yen Chi-Long Chen Jacqueline Whang-Peng Wen-Jui Lee You-Cheng Liao Yu-Ching Lee Min-Hsiung Pan Hui-Kuan Lin Huey-En Tzeng Peixuan Guo Cheng-Ying Chu Li-Ching Chen Yuan-Soon Ho |
| author_sort | Tzu-Chun Cheng |
| collection | DOAJ |
| format | Article |
| id | doaj-art-8c4c42d6e65d467f896ad1d3d79efdf9 |
| institution | Kabale University |
| issn | 2050-7771 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Biomarker Research |
| spelling | doaj-art-8c4c42d6e65d467f896ad1d3d79efdf92025-08-20T03:43:10ZengBMCBiomarker Research2050-77712025-08-011311310.1186/s40364-025-00819-6Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patientsTzu-Chun Cheng0Mien-Chie Hung1Lu-Hai Wang2Shih-Hsin Tu3Chih-Hsiung Wu4Yun Yen5Chi-Long Chen6Jacqueline Whang-Peng7Wen-Jui Lee8You-Cheng Liao9Yu-Ching Lee10Min-Hsiung Pan11Hui-Kuan Lin12Huey-En Tzeng13Peixuan Guo14Cheng-Ying Chu15Li-Ching Chen16Yuan-Soon Ho17Institute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical UniversityGraduate Institute of Biomedical Sciences, Institute of Biochemistry and Molecular Biology, Research Center for Cancer Biology, Cancer Biology and Precision Therapeutics Center, and Center for Molecular Medicine, China Medical UniversityInstitute of Integrated Medicine and Chinese Medicine Research Center, China Medical UniversityDepartment of Surgery, School of Medicine, College of Medicine, Taipei Medical UniversityDepartment of Surgery, School of Medicine, College of Medicine, Taipei Medical UniversityTMU Research Center of Cancer Translational Medicine, Taipei Medical UniversityDepartment of Pathology, School of Medicine, College of Medicine, Taipei Medical UniversityTMU Research Center of Cancer Translational Medicine, Taipei Medical UniversityInstitute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical UniversityPh.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical UniversityTMU Research Center of Cancer Translational Medicine, Taipei Medical UniversityInstitute of Food Sciences and Technology, National Taiwan UniversityDepartment of Pathology, Duke University Medical Center, Duke University School of MedicineDivision of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General HospitalCenter for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, College of Medicine, Dorothy M. Davis Heart and Lung Research Institute, and James Comprehensive Cancer Center, The Ohio State UniversityTMU Research Center of Cancer Translational Medicine, Taipei Medical UniversityDepartment of Biological Science & Technology, College of Life Sciences, China Medical UniversityInstitute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical Universityhttps://doi.org/10.1186/s40364-025-00819-6 |
| spellingShingle | Tzu-Chun Cheng Mien-Chie Hung Lu-Hai Wang Shih-Hsin Tu Chih-Hsiung Wu Yun Yen Chi-Long Chen Jacqueline Whang-Peng Wen-Jui Lee You-Cheng Liao Yu-Ching Lee Min-Hsiung Pan Hui-Kuan Lin Huey-En Tzeng Peixuan Guo Cheng-Ying Chu Li-Ching Chen Yuan-Soon Ho Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients Biomarker Research |
| title | Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients |
| title_full | Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients |
| title_fullStr | Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients |
| title_full_unstemmed | Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients |
| title_short | Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients |
| title_sort | correction histamine n methyltransferase hnmt as a potential auxiliary biomarker for predicting adaptability to anti her2 drug treatment in breast cancer patients |
| url | https://doi.org/10.1186/s40364-025-00819-6 |
| work_keys_str_mv | AT tzuchuncheng correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT mienchiehung correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT luhaiwang correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT shihhsintu correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT chihhsiungwu correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT yunyen correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT chilongchen correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT jacquelinewhangpeng correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT wenjuilee correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT youchengliao correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT yuchinglee correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT minhsiungpan correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT huikuanlin correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT hueyentzeng correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT peixuanguo correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT chengyingchu correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT lichingchen correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients AT yuansoonho correctionhistaminenmethyltransferasehnmtasapotentialauxiliarybiomarkerforpredictingadaptabilitytoantiher2drugtreatmentinbreastcancerpatients |